Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Breast Cancer Predictive Genetic Testing Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Breast Cancer Predictive Genetic Testing Market Status and Forecast (2016-2027)
      • 1.3.2 Global Breast Cancer Predictive Genetic Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Breast Cancer Predictive Genetic Testing Supply by Company

    • 2.1 Global Breast Cancer Predictive Genetic Testing Sales Value by Company
    • 2.2 Breast Cancer Predictive Genetic Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Breast Cancer Predictive Genetic Testing Market Status by Category

    • 3.1 Breast Cancer Predictive Genetic Testing Category Introduction
      • 3.1.1 High Penetrant Genes
      • 3.1.2 Intermediate Penetrant Genes
      • 3.1.3 Low Penetrant Genes
    • 3.2 Global Breast Cancer Predictive Genetic Testing Market by Category
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Breast Cancer Predictive Genetic Testing Market Status by End User/Segment

    • 4.1 Breast Cancer Predictive Genetic Testing Segment by End User/Segment
      • 4.1.1 Hospitals
      • 4.1.2 Clinics
      • 4.1.3 Others
    • 4.2 Global Breast Cancer Predictive Genetic Testing Market by End User/Segment
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Breast Cancer Predictive Genetic Testing Market Status by Region

    • 5.1 Global Breast Cancer Predictive Genetic Testing Market by Region
    • 5.2 North America Breast Cancer Predictive Genetic Testing Market Status
    • 5.3 Europe Breast Cancer Predictive Genetic Testing Market Status
    • 5.4 Asia Pacific Breast Cancer Predictive Genetic Testing Market Status
    • 5.5 Central & South America Breast Cancer Predictive Genetic Testing Market Status
    • 5.6 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Status

    6 North America Breast Cancer Predictive Genetic Testing Market Status

    • 6.1 North America Breast Cancer Predictive Genetic Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Breast Cancer Predictive Genetic Testing Market Status

    • 7.1 Europe Breast Cancer Predictive Genetic Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Breast Cancer Predictive Genetic Testing Market Status

    • 8.1 Asia Pacific Breast Cancer Predictive Genetic Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Breast Cancer Predictive Genetic Testing Market Status

    • 9.1 Central & South America Breast Cancer Predictive Genetic Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Breast Cancer Predictive Genetic Testing Market Status

    • 10.1 Middle East & Africa Breast Cancer Predictive Genetic Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Breast Cancer Predictive Genetic Testing Market Forecast by Category and by End User/Segment

    • 12.1 Global Breast Cancer Predictive Genetic Testing Sales Value Forecast (2022-2027)
    • 12.2 Global Breast Cancer Predictive Genetic Testing Forecast by Category
    • 12.3 Global Breast Cancer Predictive Genetic Testing Forecast by End User/Segment

    13 Global Breast Cancer Predictive Genetic Testing Market Forecast by Region/Country

    • 13.1 Global Breast Cancer Predictive Genetic Testing Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Thermo Fisher Scientific
      • 14.1.1 Company Information
      • 14.1.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.1.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Roche
      • 14.2.1 Company Information
      • 14.2.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.2.3 Roche Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Quest Diagnostics
      • 14.3.1 Company Information
      • 14.3.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.3.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 PerkinElmer
      • 14.4.1 Company Information
      • 14.4.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.4.3 PerkinElmer Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 OncoCyte Corporation
      • 14.5.1 Company Information
      • 14.5.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.5.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 NeoGenomics
      • 14.6.1 Company Information
      • 14.6.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.6.3 NeoGenomics Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Myriad Genetics
      • 14.7.1 Company Information
      • 14.7.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.7.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Iverson Genetics
      • 14.8.1 Company Information
      • 14.8.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.8.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Invitae
      • 14.9.1 Company Information
      • 14.9.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.9.3 Invitae Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Cancer Genetics
      • 14.10.1 Company Information
      • 14.10.2 Breast Cancer Predictive Genetic Testing Product Introduction
      • 14.10.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Breast Cancer Predictive Genetic Testing market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Breast Cancer Predictive Genetic Testing market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      High Penetrant Genes
      Intermediate Penetrant Genes
      Low Penetrant Genes

      Segmented by End User/Segment
      Hospitals
      Clinics
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Thermo Fisher Scientific
      Roche
      Quest Diagnostics
      PerkinElmer
      OncoCyte Corporation
      NeoGenomics
      Myriad Genetics
      Iverson Genetics
      Invitae
      Cancer Genetics
      Buy now